Director, Patient and Provider Access Support Services

About Summit: Summit Therapeutics Inc. is a biopharmaceutical oncology company with a mission focused on improving quality of life, increasing potential duration of life, and resolving serious unmet medical needs. At Summit, we believe in building a team of world class professionals who are passionate about this mission, and it is our people who drive this mission to reality. Summit’s core values include integrity, passion for excellence, purposeful urgency, collaboration, and our commitment to people. Our employees are truly the heart and soul of our culture, and they are invaluable in shaping our journey toward excellence. Summit’s team is inspired to touch and help change lives through Summit’s clinical studies in the field of oncology. Summit has multiple global Phase 3 clinical studies, including: Non-small Cell Lung Cancer (NSCLC) HARMONi: Phase 3 clinical study which was intended to evaluate ivonescimab combined with chemotherapy compared to placebo plus chemotherapy in patients with EGFR-mutated, locally advanced or metastatic non-squamous NSCLC who were previously treated with a 3rd generation EGFR TKI. HARMONi-3: Phase 3 clinical study which is intended to evaluate ivonescimab combined with chemotherapy compared to pembrolizumab combined with chemotherapy in patients with first-line metastatic NSCLC. HARMONi-7: Phase 3 clinical study which is intended to evaluate ivonescimab monotherapy compared to pembrolizumab monotherapy in patients with first-line metastatic NSCLC. Colorectal Cancer (CRC) HARMONi-GI3: Phase 3 clinical study intended to evaluate ivonescimab in combination with chemotherapy compared with bevacizumab plus chemotherapy. Ivonescimab is an investigational therapy not presently approved by any regulatory authority other than China’s National Medical Products Administration (NMPA). Summit is headquartered in Miami, Florida, and has additional offices in California, New Jersey, the UK, and Ireland. Overview of Role: We are seeking a Director of Patient Services responsible for the strategic oversight and continuous evolution of Summit Therapeutics’ patient support programs. This role will lead the execution and optimization of high-impact services to ensure patients receive timely, coordinated access to therapy. The Director will manage third-party vendors, monitor operational performance, and partner cross-functionally to enhance the overall patient experience, ensure compliance, and remove barriers to access. This role plays a critical part in supporting patient access and successful commercialization. This position reports to the Sr. Director, Trade, Distribution & Patient Services. Role and Responsibilities: Lead design and execution of HUB, copay, and patient assistance programs Support oncology launch planning and execution Manage vendors and performance Coordinate with outsourced Field Reimbursement Managers (FRMs) to align patient services with field reimbursement support and provider needs Partner across Market Access, Commercial, Medical, Trade, and Compliance, Finance Track KPIs (time to therapy, approvals, adherence) Identify insights from the field and translate them into actionable strategies to enhance patient access and support Partner with Market Access Strategy to develop appropriate tools and resources for service offerings Ensure compliance with legal and regulatory requirements Continuously improve patient experience All other duties as assigned Experience, Education and Specialized Knowledge and Skills: Bachelor’s degree required; advanced degree preferred Minimum of 10+ years of experience in Patient Services, Market Access, or related functions Oncology or specialty product experience required Demonstrated experience supporting product launches Strong understanding of HUB services, reimbursement, and patient access models Strong understanding of oncology patient access and reimbursement, including buy-and-bill dynamics, provider economics, and site-of-care considerations across co…